GLIG Rankings digest · October 2026

Who leads Gulf longevity

Abu Dhabi's health groups take the top four places among companies. Capital is the region's strongest suit; growth momentum its weakest.

No. 1 · Abu Dhabi, UAE · Healthspan Tech / AI

M42

The region's broadest platform: 480+ facilities in 27 countries, with genomics and AI built into prevention.

94.5Index /100
Scale
10
Capital
10
Science
9
Clinical
9
Ecosystem
10
Growth
8
No. 289.0

PureHealth

Abu Dhabi, UAE · Healthcare Group (longevity unit)

The Middle East's largest integrated healthcare platform, with scale and capital to match.

No. 388.0

G42 Healthcare & Life Sciences

Abu Dhabi, UAE · Healthspan Tech / AI

AI, omics and diagnostics aimed at moving care from reactive to proactive.

Part of M42; 50+ specialties. Rank only a dedicated preventive or longevity programme. (UAE Preferred)

Scale
9
Capital
9
Science
8
Clinical
9
Ecosystem
8
Growth
5

Regenerative medicine, cell therapy and transplant research and development centre.

Scale
7
Capital
8
Science
9
Clinical
9
Ecosystem
8
Growth
6

Largest private hospital group in the Kingdom — identify the preventive or longevity unit. Profile pending source verification.

Scale
10
Capital
9
Science
5
Clinical
9
Ecosystem
7
Growth
7

Research-intensive hospital with genomic medicine capability — identify the preventive unit. Profile pending source verification.

Scale
7
Capital
9
Science
8
Clinical
9
Ecosystem
7
Growth
5

PIF-backed biopharmaceutical manufacturing company — confirm healthspan relevance of the portfolio. Profile pending source verification.

Scale
7
Capital
9
Science
7
Clinical
7
Ecosystem
8
Growth
7

Health information exchange operated by M42; longitudinal population health data. (m42.ae)

Scale
7
Capital
8
Science
7
Clinical
8
Ecosystem
9
Growth
6

Listed hospital group — identify the longevity or wellness unit before scoring. Profile pending source verification.

Scale
9
Capital
9
Science
5
Clinical
8
Ecosystem
6
Growth
7
Scale 20%Capital 20%Science 20%Clinical 15%Ecosystem 15%Growth 10%VerifiedTo verify

Six weighted criteria scored 0–10 by analysts: scale & market reach 20%, capital & financial strength 20%, science & innovation 20%, clinical & regulatory credibility 15%, ecosystem influence 15%, growth momentum 10%. Final analytical edition, 1 October 2026.